NA Semax Amidate

NA Semax Amidate

NA Semax Amidate

NA Semax Amidate is a structure-optimized analog of semax. It is an N-terminally acetylated and C-terminally amidated derivative of the Semax peptide, which preserves the core sequence.

 

SKU: 198886 Turkum:
Sevgingizni baham ko'ring

NA Semax Amidate is a structure-optimized analog of semax. It is an N-terminally acetylated and C-terminally amidated derivative of the Semax peptide, which preserves the core sequence.

This artificial modification markedly improves the resistance of the peptide chain against exo- and endopeptidases (for example leucine aminopeptidase), extending its half-life by about 30 minutes compared with the original Semax, with an overall duration of action of 6-12 soat.

It also enhances room temperature storage stability and nasal mucosal absorption efficiency, thereby ensuring more reliable penetration of the blood-brain barrier (BBB) and the sustained maintenance of an effective concentration gradient in brain tissue.

Its core mechanism lies in multi-pathway modulation of central nervous system funktsiyasi.

First and foremost, NA Semax Amidate acts as a powerful upregulator of miyadan kelib chiqqan neyrotrofik omil (BDNF), which in turn enhances neuronal survival, axonal growth, sinaptik plastika va long-term potentiation (LTP) — the molecular basis for learning and memory.

Moreover,NA Semax Amidate potentiates dopaminergic, serotonergic, and noradrenergic neurotransmission, thereby optimizing prefrontal cortex executive functions, including attention selectivity and working memory sig'im.

NA Semax Amidate also exhibits significant neuroprotective effects by suppressing inflammatory cytokine release, reducing oxidative stress damage, and stabilizing mitochondrial membrane potential.

It is effective against various pathological insults such as cerebral ischemia, gipoksiya, trauma, va neurodegeneration.

It is approved in Russia as adjunctive therapy for acute stroke, traumatic brain injury, and early-stage Parkinson’s disease.

qisqa bayoni; yakunida, NA Semax Amidate utilizes chemical modifications to overcome the limitations of the natural peptide, thereby surpassing conventional Semax in cognitive enhancement, neuroprotection, mood regulation, and injury repair.

This holds significant clinical importance for the treatment of neyrodegenerativ kasalliklar and the promotion of central nervous system functional recovery.

Ketma-ketlik

AC-met-glu-his-phe-pro-gly-pro-nh2

CAS raqami

/

Molekulyar formula

C39H54N10O10S

Molekulyar og'irlik

854.98

Research Of NA Semax Amidate

NA Semax Amidate demonstrates efficacy comparable to classical anxiolytic drugs in several preclinical models.

1.Cognitive Enhancement and Neural Plasticity

NA Semax Amidate activates the transcription factor CREB, upregulating BDNF gene expression and increasing neuronal BDNF levels by over 40%.

This in turn promotes dendritic spine shakllanishi, axonal guidance, and aggregation of postsynaptic density protein 95 (PSD-95), thereby enhancing learning capacity.

Biological simulation experiments demonstrate a 35-50% improvement in memory retention rates in contextual fear conditioning tests.

Brain slice electrophysiological recordings confirm increased LTP amplitude and duration, indicating that NA Semax Amidate reshapes sinaptik plastika thresholds through profound activation of the neyrotrofik omil network.

2.Neuroprotection and Repair

NA Semax Amidate activates the adenylate cyclase (AC)-cAMP-PKA pathway to stabilize mitoxondrial membrane potential, inhibits cytochrome C release, and suppresses caspase-3 cascade activation, thereby blocking the execution phase of apoptoz.

Concurrently, it upregulates superoksid dismutaza expression and inhibits excessive inflammatory sitokin ishlab chiqarish.

In a rat middle cerebral artery occlusion model, it reduced cerebral infarction volume by over 50%.

In an MPTP model of Parkinson’s disease, it increased dopaminergic neuron survival by 35%, demonstrating potent neuroprotection.

3.Anxiolytic and Analgesic Effects

NA Semax Amidate increases affinity for endogenous enkephalins va b-endorfin while inhibiting G protein-coupled receptor kinase (GRK)-mediated receptor internalization and desensitization, thereby prolonging analgesic signalizatsiya.

It also reduces FTO-mediated inflammatory pain hypersensitivity.

In mouse models, pain thresholds were elevated by 30-40% and remained elevated for 4 uchun 6 soat.

In chronic constriction injury (CCI) models, mechanical allodynia was alleviated by 50%, further confirming NA Semax Amidate’s clear anti-stress and mood-stabilizing properties.

NA Semax Amidate demonstrates efficacy comparable to classical anxiolytic drugs in several preclinical models.

4.Cognitive Enhancement and Neural Plasticity

NA Semax Amidate activates the transcription factor CREB, upregulating BDNF gene expression and increasing neuronal BDNF levels by over 40%.

This in turn promotes dendritic spine formation, axonal guidance, and aggregation of postsynaptic density protein 95 (PSD-95), thereby enhancing learning capacity.

Biological simulation experiments demonstrate a 35-50% improvement in memory retention rates in contextual fear conditioning tests.

Brain slice electrophysiological recordings confirm increased LTP amplitude and duration, indicating that NA Semax Amidate reshapes synaptic plasticity thresholds through profound activation of the neurotrophic factor network.

5.Neuroprotection and Repair

NA Semax Amidate activates the adenylate cyclase (AC)-cAMP-PKA pathway to stabilize mitochondrial membrane potential, inhibits cytochrome C release, and suppresses caspase-3 cascade activation, thereby blocking the execution phase of apoptosis.

Concurrently, it upregulates superoxide dismutase expression and inhibits excessive inflammatory cytokine production.

In a rat middle cerebral artery occlusion model, it reduced cerebral infarction volume by over 50%.

In an MPTP model of Parkinson’s disease, it increased dopaminergic neuron survival by 35%, demonstrating potent neuroprotection.

6.Anxiolytic and Analgesic Effects

NA Semax Amidate increases affinity for endogenous enkephalins and β-endorphin while inhibiting G protein-coupled receptor kinase (GRK)-mediated receptor internalization and desensitization, thereby prolonging analgesic signaling.

It also reduces FTO-mediated inflammatory pain hypersensitivity.

In mouse models, pain thresholds were elevated by 30-40% and remained elevated for 4 uchun 6 soat.

In chronic constriction injury (CCI) models, mechanical allodynia was alleviated by 50%, further confirming NA Semax Amidate’s clear anti-stress and mood-stabilizing properties.

COA

HPLC

XONIM

(1) Dmitrieva, V. G.; Povarova, O. V.; Skvortsova, V. I.; Limborska, S. A.; Myasoedov, N. F.; Dergunova, L. V. Semax va Pro-Gly-Pro miya ishemiyasidan keyin neyrotrofinlar va ularning retseptorlari genlarining transkripsiyasini faollashtiradi.. Uyali va molekulyar neyrobiologiya 2009, 30 (1), 71-79. DOI: 10.1007/s10571-009-9432-0.

(2) Eremin, K. O.; Kudrin, V. S.; Saransari, P.; Mahsulot, S. S.; Grivennikov, I. A.; Myasoedov, N. F.; Rayevskiy, K. S. Eshitmang, ACTH(4-10) Nootropik xususiyatlarga ega analog, Kemiruvchilarda dopaminerjik va serotoninerjik miya tizimlarini faollashtiradi. Neyrokimyoviy tadqiqotlar 2005, 30 (12), 1493-1500. DOI: 10.1007/s11064-005-8826-8.

(3) Glazova, N. Y.; Manchenko, D. M.; Volodina, M. A.; Merchieva, S. A.; Andreeva, L. A.; Kudrin, V. S.; Myasoedov, N. F.; Levitskaya, N. G. Eshitmang, sintetik ACTH(4-10) analog, oq kalamushlarda erta hayotda fluvoksamin ta'siridan keyin xulq-atvor va neyrokimyoviy o'zgarishlarni susaytiradi.. Neyropeptidlar 2021, 86. DOI: 10.1016/j.npep.2020.102114.

(4) Narxi, N. V.; Sokolov, O.; Gabaeva, M. V.; Grivennikov, I. A.; Andreeva, L. A.; Miasoedov, N. F.; Zozuliya, A. A. [Semax va selank inson zardobidagi enkefalinni buzuvchi fermentlarni inhibe qiladi]]. Bioorg Khim 2001, 27 (3), 180-183. DOI: 10.1023/a:1011373002885 NLM Medline'dan.

(5) Medvedeva, E. V.; Dmitrieva, V. G.; Limborska, S. A.; Myasoedov, N. F.; Dergunova, L. V. Eshitmang, ACTH ning analogi(4−7), kalamushlarda ishemik miya shikastlanishi paytida immun javob genlarining ifodasini tartibga soladi. Molekulyar genetika va genomika 2017, 292 (3), 635-653. DOI: 10.1007/s00438-017-1297-1.

(6) Pae, C.-U. Depressiya uchun "Semax" ning terapevtik imkoniyati. CNS spektrlari 2014, 13 (1), 20-21. DOI: 10.1017/s1092852900016102.

(7) Vlasova, I. M.; Buravtkov, D. E.; Saletskiy, A. M. Miya ishemiyasida "Semax" preparatining neyroprotektiv xususiyatlarini o'rganishda qon tarkibiy qismlarining luminesans tahlili. Amaliy spektroskopiya jurnali 2009, 76 (1), 121-126. DOI: 10.1007/s10812-009-9141-y.

Ketma-ketlik:

AC-met-glu-his-phe-pro-gly-pro-nh2

CAS:

/

M.V:

854.98 g/mol

Uy Qidiruv Whatsapp Xizmatlar Mahsulot